Expanding the Evidence for Behavioral Interventions in Gastroenterology
Recent research underscores the significance of psychological factors in managing gastrointestinal (GI) conditions, revealing how addressing these aspects can enhance patient outcomes. The findings call for more integrated approaches that include mental health support in GI treatment protocols.
Introduction to the Research in Gastroenterology
The Division of Gastroenterology and Hepatology at Feinberg has been focusing on the role of behavior and lifestyle choices in gastrointestinal health. This initiative was inspired by observations made by John Pandolfino, MD, GME, who noticed that some patients experienced persistent symptoms even after undergoing esophageal surgery. This led to a collaborative effort to explore how mental health impacts treatment outcomes.
Developing Tools to Measure Psychological Factors
In partnership with Laurie Keefer, Ph.D., and other colleagues, the team created measures like the Esophageal Hypervigilance and Anxiety Scale (EHAS) and the Northwestern Esophageal Quality of Life Scale. These tools aim to assess psychological processes that could be influencing patients’ symptom experiences and overall quality of life, opening avenues for additional treatment options beyond traditional medical or surgical interventions.
Linking Hypervigilance to GI Disorders
In gastrointestinal disorders such as irritable bowel syndrome (IBS), Crohn’s disease, and various esophageal conditions, patients often exhibit hypervigilance—a heightened sensitivity to bodily sensations. Livia Guadagnoli, Ph.D., has conducted research that indicates a correlation between increased hypervigilance and anxiety with poorer treatment outcomes, particularly in patients with achalasia, a rare esophageal motility disorder. The study demonstrated that higher baseline scores for hypervigilance and anxiety were predictive of greater symptom severity and reduced quality of life after treatment.
Guadagnoli’s findings suggest that addressing these psychological factors prior to or during treatment could lead to more favorable outcomes. Specifically, early psychological intervention could potentially mitigate the impact of hypervigilance and anxiety on symptom severity.
Behavioral Interventions and Their Effectiveness
The research team is also examining the effectiveness of behavioral interventions aimed at alleviating GI conditions. The focus is on cognitive-behavioral approaches to see if they can help manage symptoms like those found in gastroesophageal reflux disease (GERD) and functional heartburn. Sara Hoffman, Ph.D., emphasizes that empowering patients with skills to manage their conditions significantly impacts their experience and quality of life.
As research progresses, the team is committed to bridging the gap between clinical practice and research. With over 1,300 annual referrals, the psychologists in the division provide therapy sessions to help patients address psychological aspects that can impede their GI health. By identifying gaps in care and researching solutions, they aim to establish a clearer understanding of how psychological factors influence physiological health in GI conditions.
THE CNP TAKEAWAY
Integrating behavioral interventions into gastrointestinal treatments can improve patient outcomes by addressing psychological factors such as anxiety and hypervigilance. Further research is necessary to solidify the role of these interventions in clinical practice.
Images courtesy of Shutterstock.
This article was prepared by CNP based on reporting originally published by Haleigh Ehmsen, at Northwestern University. Read the original news article on: medicalxpress.com or find the CNP study summary in the NPRL.
